Infectious Disease Clinical Research
“Our mission is to seamlessly partner with our pharmaceutical industry customers to tackle the ongoing and evolving challenges of unmet needs across the spectrum of global infectious diseases. We bring to our customers solid and varied therapeutic expertise, innovative traditional and decentralized trial delivery solutions, and track records of consistent operational delivery, performance and execution. We are particularly proud of our significant contributions to COVID-19 therapeutics development and are positioned optimally for anticipated post-COVID syndrome solutions.”
GLOBAL INVESTIGATOR NETWORK FOR INFECTIOUS DISEASE RESEARCH
PPD’s global investigator database includes infectious disease specialists in pediatric indications, HIV, chronic hepatitis B and C, COVID-19, influenza as well as bacterial, fungal and parasitic diseases. With experience of more than 470 studies across 54 different indications in the past five years alone, you can count on us to deliver investigators and sites with proven trial experience. In addition, our suite of digital and decentralized trial solutions is designed to increase clinical trial access for patients while improving their overall experience.
HIV DRUG DEVELOPMENT AND RESEARCH LEADER
We have experience with both short-and long-term HIV trials as well as concomitant programs for multiple Phase III studies. Our extensive experience includes trials addressing opportunistic infections, co-infections, and highly active antiretroviral therapies (HAART). In the last five years we have conducted more than 260 HIV studies with more than 119,000 patients. We work successfully with governments and commercial clients to deliver high-quality data that you can use to make important decisions about your candidate drug. Together with our customers we are exploring new approaches to HIV treatment studies and we work diligently to ensure our site and patient strategies include traditionally overlooked populations.
HIV Drug Studies Experience
In the past five years we have conducted more than 260 HIV studies with more than 119,000 patients.
Our Covid-19 EXPERIENCE
PPD LABORATORIES’ SERVICES FOR INFECTIOUS DISEASE CLINICAL TRIALS
In addition to a broad array of safety testing available through our central lab, PPD also offers microbiology and molecular genomic testing to support infectious disease trials globally.
- Extensive virology testing, including real-time polymerase chain reaction, viral load, genotyping and single nucleotide polymorphism analysis
- The capability to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms
- A flexible approach to microbiology testing, performing disk diffusion and/or broth dilution assays to establish antibiotic minimum inhibitory concentration and breakpoints
- Strategic locations in the US, E.U and Asia to support trials of all sizes.